Search research articles
Contact Us
Filters
Showing results (41-50 of 85) with videos related to
Page
of 9
Sort By:
Infectious Diseases and Therapy
|
January 7, 2022
A Cross-Sectional Concept Elicitation Study to Understand the Impact of Herpes Zoster on Patients' Health-Related Quality of Life
Desirée Van Oorschot, Ashleigh McGirr, Philibert Goulet, et al.
Dermatology and Therapy
|
April 23, 2018
The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model Analysis
Daisuke Watanabe, Akiko Mizukami, Katsiaryna Holl, et al.
Dermatology and Therapy
|
April 1, 2019
Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older
Makoto Shiragami, Akiko Mizukami, Toshihiko Kaise, et al.
Human Vaccines & Immunotherapeutics
|
July 26, 2017
Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease
Zobair Younossi, Katrin Kochems, Marc de Ridder, et al.
Advances in Therapy
|
May 20, 2021
Economic Burden and Impact on Quality of Life of Herpes Zoster in Spanish Adults Aged 50 Years or Older: A Prospective Cohort Study
Javier Díez-Domingo, Desmond Curran, Maria Del Rosario Cambronero, et al.
Infectious Diseases and Therapy
|
December 7, 2021
Meta-Regression of Herpes Zoster Incidence Worldwide
Desmond Curran, Andrea Callegaro, Kyle Fahrbach, et al.
Statistics in Medicine
|
December 17, 2002
Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection
Kristel Van Steen, Desmond Curran, Jocelyn Kramer, et al.
Dermatology and Therapy
|
June 6, 2022
Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults
Lida Teng, Akiko Mizukami, Cheryl Ng, et al.
Open Forum Infectious Diseases
|
April 10, 2026
Age-specific Risk of Herpes Zoster in Immunocompetent Adults ≥18 Years-of-age-A Retrospective Cohort Study in the United States
Rachel A Cohen, Driss Oraichi, Agnes Mwakingwe-Omari, et al.
The Clinical Journal of Pain
|
May 11, 2023
An Analysis of How Herpes Zoster Pain Affects Health-related Quality of Life of Placebo Patients From 3 Randomized Phase III Studies
Sean Matthews, Desmond Curran, Eliazar Sabater Cabrera, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 85) with videos related to
Sort By:
Page
of 9
Infectious Diseases and Therapy
|
January 7, 2022
A Cross-Sectional Concept Elicitation Study to Understand the Impact of Herpes Zoster on Patients' Health-Related Quality of Life
Desirée Van Oorschot, Ashleigh McGirr, Philibert Goulet, et al.
Dermatology and Therapy
|
April 23, 2018
The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model Analysis
Daisuke Watanabe, Akiko Mizukami, Katsiaryna Holl, et al.
Dermatology and Therapy
|
April 1, 2019
Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older
Makoto Shiragami, Akiko Mizukami, Toshihiko Kaise, et al.
Human Vaccines & Immunotherapeutics
|
July 26, 2017
Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease
Zobair Younossi, Katrin Kochems, Marc de Ridder, et al.
Advances in Therapy
|
May 20, 2021
Economic Burden and Impact on Quality of Life of Herpes Zoster in Spanish Adults Aged 50 Years or Older: A Prospective Cohort Study
Javier Díez-Domingo, Desmond Curran, Maria Del Rosario Cambronero, et al.
Infectious Diseases and Therapy
|
December 7, 2021
Meta-Regression of Herpes Zoster Incidence Worldwide
Desmond Curran, Andrea Callegaro, Kyle Fahrbach, et al.
Statistics in Medicine
|
December 17, 2002
Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection
Kristel Van Steen, Desmond Curran, Jocelyn Kramer, et al.
Dermatology and Therapy
|
June 6, 2022
Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults
Lida Teng, Akiko Mizukami, Cheryl Ng, et al.
Open Forum Infectious Diseases
|
April 10, 2026
Age-specific Risk of Herpes Zoster in Immunocompetent Adults ≥18 Years-of-age-A Retrospective Cohort Study in the United States
Rachel A Cohen, Driss Oraichi, Agnes Mwakingwe-Omari, et al.
The Clinical Journal of Pain
|
May 11, 2023
An Analysis of How Herpes Zoster Pain Affects Health-related Quality of Life of Placebo Patients From 3 Randomized Phase III Studies
Sean Matthews, Desmond Curran, Eliazar Sabater Cabrera, et al.
Page
of 9